SUSTOL

Product NDC
47426-101
11-digit product format
474260101
Labeler code
47426
Product ID
47426-101_d4d4e836-ebba-4666-b6da-9d5a846dfcf8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
granisetron
Dosage form
INJECTION
Route
SUBCUTANEOUS
Labeler
Heron Therapeutics, Inc.
Application
NDA022445
Marketing category
NDA
Marketing start
2016-08-09
Substance
GRANISETRON
Active strength
10 mg/.4mL
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
SUSTOL
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
GRANISETRON10 mg/.4mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiWZG3J2MCOL
Rxcui1810484, 1810489

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
cfd5f35c-827b-432c-9fef-0869f8899c80Product name120260105
bd0ef290-bb63-6056-ab17-adf968a44900Product name220170616
d7be5b36-17f0-843a-22b1-df15cb96e594Product name320170616
e5d20d92-e4d9-43c9-9475-8f368311d104Product name220170501
5a6fb99e-671a-4b1d-a9dc-1e7566682136Product name120160831
5c6cdff6-4525-6e4a-2964-09019d52be11Product name120140508
ae524849-1812-2c3b-219e-58a687215e77Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
47426-101-012024-10-06C16284748780-11e7a6dab-1c7c-a2ce-e063-dadaa90aadf7These highlights do not include all the information needed to use SUSTOL ® safely and effectively. See full prescribing information for SUSTOL. SUSTOL ® (granisetron) extended-release injection, for subcutaneous use Initial U.S. Approval: 1993
47426-101-012024-10-06C16284748780-11e7a6dab-1c7c-a2ce-e063-dadaa90aadf7These highlights do not include all the information needed to use SUSTOL ® safely and effectively. See full prescribing information for SUSTOL. SUSTOL ® (granisetron) extended-release injection, for subcutaneous use Initial U.S. Approval: 1993
47426-101-062024-10-06C16284748780-11e7a6dab-1c7c-a2ce-e063-dadaa90aadf7These highlights do not include all the information needed to use SUSTOL ® safely and effectively. See full prescribing information for SUSTOL. SUSTOL ® (granisetron) extended-release injection, for subcutaneous use Initial U.S. Approval: 1993
47426-101-062024-10-06C16284748780-11e7a6dab-1c7c-a2ce-e063-dadaa90aadf7These highlights do not include all the information needed to use SUSTOL ® safely and effectively. See full prescribing information for SUSTOL. SUSTOL ® (granisetron) extended-release injection, for subcutaneous use Initial U.S. Approval: 1993
47426-101-012024-07-30C16284748780-11e7a6dab-1c7c-a2ce-e063-dadaa90aadf7These highlights do not include all the information needed to use SUSTOL ® safely and effectively. See full prescribing information for SUSTOL. SUSTOL ® (granisetron) extended-release injection, for subcutaneous use Initial U.S. Approval: 1993
47426-101-012024-07-30C16284748780-11e7a6dab-1c7c-a2ce-e063-dadaa90aadf7These highlights do not include all the information needed to use SUSTOL ® safely and effectively. See full prescribing information for SUSTOL. SUSTOL ® (granisetron) extended-release injection, for subcutaneous use Initial U.S. Approval: 1993
47426-101-062024-07-30C16284748780-11e7a6dab-1c7c-a2ce-e063-dadaa90aadf7These highlights do not include all the information needed to use SUSTOL ® safely and effectively. See full prescribing information for SUSTOL. SUSTOL ® (granisetron) extended-release injection, for subcutaneous use Initial U.S. Approval: 1993
47426-101-062024-07-30C16284748780-11e7a6dab-1c7c-a2ce-e063-dadaa90aadf7These highlights do not include all the information needed to use SUSTOL ® safely and effectively. See full prescribing information for SUSTOL. SUSTOL ® (granisetron) extended-release injection, for subcutaneous use Initial U.S. Approval: 1993

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
47426-101-01SUSTOL1 in 1 KITINJECTION110
47426-101-01SUSTOL1 in 1 CARTONINJECTION110
47426-101-06SUSTOL6 in 1 CARTONINJECTION610
47426-101-06SUSTOL1 in 1 KITINJECTION110

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
47426-101-01ML - Milliliter47426-10101baefcf-7671-4c9f-9d32-69806574e9a212016-11-08
47426-101-06ML - Milliliter47426-101ffb74299-59b1-4f50-8675-a69fc101d4fe12016-11-08

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
47426-101SUSTOL (GRANISETRON) INJECTION [HERON THERAPEUTICS, INC.]7Current NDC, Legacy NDC, 4 package rows20241008_f7c7ffdd-8270-4030-bc1e-a1cb28a6de56.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1810484granisetron 10 MG in 0.4 ML Prefilled SyringePSNf7c7ffdd-8270-4030-bc1e-a1cb28a6de5610
1810489sustol 10 MG in 0.4 ML Prefilled SyringePSNf7c7ffdd-8270-4030-bc1e-a1cb28a6de5610
18104890.4 ML granisetron 25 MG/ML Prefilled Syringe [Sustol]SBDf7c7ffdd-8270-4030-bc1e-a1cb28a6de5610
18104840.4 ML granisetron 25 MG/ML Prefilled SyringeSCDf7c7ffdd-8270-4030-bc1e-a1cb28a6de5610
18104890.4 ML Sustol 25 MG/ML Prefilled SyringeSYf7c7ffdd-8270-4030-bc1e-a1cb28a6de5610
1810484granisetron 10 MG per 0.4 ML Prefilled SyringeSYf7c7ffdd-8270-4030-bc1e-a1cb28a6de5610
1810489Sustol 10 MG per 0.4 ML Prefilled SyringeSYf7c7ffdd-8270-4030-bc1e-a1cb28a6de5610

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
47426-101-01474260101011 in 1 KITHistorical
47426-101-06474260101066 KIT in 1 CARTON (47426-101-06) / 1 SYRINGE, GLASS in 1 KIT / .4 mL in 1 SYRINGE, GLASS6 kit2016-08-090000-00-00NoNoCurrent